JCIC Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
JCIC Asset Management's BMY Position: Q2 2026 in Review
JCIC Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 875 shares worth $53.1K. The position accounts for 0.02% of the portfolio, ranked #80.
JCIC Asset Management first reported a position in BMY in Q1 2020 and has held it in 25 quarters since. The position peaked at $154K in Q2 2021. 566 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- JCIC Asset Management held 875 shares of Bristol-Myers Squibb worth $53.1K as of Q2 2026.
- JCIC Asset Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.02% of JCIC Asset Management's portfolio in Q2 2026, its #80 holding.
- JCIC Asset Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 25 quarters since.
- JCIC Asset Management's Bristol-Myers Squibb position peaked at $154K in Q2 2021.
- 566 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on JCIC Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.